Literature DB >> 1335296

Anti-Epstein-Barr virus-nuclear antigen-1, -2A and -2B antibodies in rheumatoid arthritis patients and their relatives.

P Youinou1, M Buisson, J M Berthelot, C Jamin, P Le Goff, O Genoulaz, A Lamour, P M Lydyard, J M Seigneurin.   

Abstract

We have examined serum antibodies to Epstein-Barr virus Nuclear Antigen (EBNA)-1, -2A and -2B, in addition to antibodies to viral capsid antigen and early antigen in 100 rheumatoid arthritis patients and 50 of their relatives. Using indirect immunofluorescence on transfected cells and Western-blot technique, we have found increased frequency and titres of antibodies to EBNA-2B in patients and, to a lesser degree, in their family members, whereas other anti-Epstein-Barr virus antibodies appeared to be similar to controls. Cross-inhibition experiments were carried out and show that antibodies to EBNA-2A are distinct from those to -2B, and vice versa.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335296     DOI: 10.3109/08916939209004828

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  6 in total

1.  Spontaneous establishment of an Epstein-Barr virus-infected fibroblast line from the synovial tissue of a rheumatoid arthritis patient.

Authors:  J Koide; K Takada; M Sugiura; H Sekine; T Ito; K Saito; S Mori; T Takeuchi; S Uchida; T Abe
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 2.  The Epstein-Barr virus in autoimmunity.

Authors:  J H Vaughan
Journal:  Springer Semin Immunopathol       Date:  1995

3.  Atypical prediagnosis Epstein-Barr virus serology restricted to EBV-positive Hodgkin lymphoma.

Authors:  Lynn I Levin; Ellen T Chang; Richard F Ambinder; Evelyne T Lennette; Mark V Rubertone; Risa B Mann; Michael Borowitz; Edward G Weir; Susan L Abbondanzo; Nancy E Mueller
Journal:  Blood       Date:  2012-09-12       Impact factor: 22.113

4.  Anti-EBNA1/anti-EBNA2 ratio decreases significantly in patients with progression of HIV infection.

Authors:  B Winkelspecht; F Grässer; H W Pees; N Mueller-Lantzsch
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

5.  EBV-Associated Cancer and Autoimmunity: Searching for Therapies.

Authors:  Giovanni Capone; Candida Fasano; Guglielmo Lucchese; Michele Calabrò; Darja Kanduc
Journal:  Vaccines (Basel)       Date:  2015-02-05

Review 6.  Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis.

Authors:  Robert J Ball; Alison Avenell; Lorna Aucott; Peter Hanlon; Mark A Vickers
Journal:  Arthritis Res Ther       Date:  2015-09-29       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.